CCL vs MREO · P/E 15, rev $12.83B vs $48.7M cap
Carnival Corporation (CCL) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported CCL revenue for 2026-05-31 was $12.83B. Net income was $795.0M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. MREO currently screens at market cap $48.7M.
Not investment advice. Open the CCL and MREO stock pages for the full models.
Not investment advice.